Manitoba Health advises that a Pfizer infant vaccine was recently recommended for use in children aged six months to four years old. Most parents and caregivers who make a first vaccine appointment for a child in this age group should expect the Pfizer infant vaccine will be offered.
On Oct. 7, Health Canada approved the use of a second bivalent vaccine, which can be used for people aged 12 and up. Manitoba Health is now expanding eligibility for the bivalent COVID-19 booster vaccine to include anyone aged 12 or older.
Manitoba Health advises that people who are eligible for the bivalent COVID-19 vaccine can begin booking appointments on Sept. 12 at 9 a.m.
Manitoba Health is announcing the first groups who are eligible to receive the COVID-19 bivalent vaccine, which was approved by Health Canada earlier this week for people aged 18 and older.
Manitoba Health is advising that all children aged five to 11 can now receive a booster dose of the Pfizer COVID-19 vaccine. A booster dose is particularly important for children with an underlying medical condition that places them at high risk of severe illness due to COVID-19.
Starting today, Friday, August 5, Manitoba Health is expanding COVID-19 vaccine eligibility to include all children aged six months to four years.
Manitoba Health is expanding COVID-19 vaccine eligibility to include children ages six months to four years. This follows federal approval of the Moderna COVID-19 vaccine for children in this age group, as well as clinical guidance from the National Advisory Committee on Immunization (NACI).
Health Minister Audrey Gordon announced that the Manitoba government is seeking feedback from Manitobans on emerging COVID-19 vaccination plans for young children.
As COVID-19 continues to spread rapidly within the province, and death rates continue to climb, Manitoba is expanding eligibility for the second booster dose of COVID-19 vaccine.
Based on updated recommendations from the National Advisory Committee on Immunization, Manitoba Health is revising its guidance on booster doses of COVID-19 vaccine for young people aged 12 to 17.
